A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery

Stopped early · Phase 4

Conditions studied: Postoperative Nausea and Vomiting, Respiratory Conditions Due to Other External Agents

In brief

The investigators will track bariatric patients who received sugammadex versus neostigmine in the post anesthesia care unit until discharge and assess their length of stay and possible nausea / vomiting / hypoxia episodes.

Key facts

Study ID

NCT03276026

Run by

Virtua Health, Inc.

People needed

68

Starts

2018-02-12

Expected to finish

2018-11-08

Last updated by the study team

2019-05-28

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients having sleeve gastrectomy
• Surgeries performed by a particular surgeon - Dr. Sam Wasser
• Body Mass Index greater than 35
• American Society of Anesthesiologists Score II and III patients

You may not qualify if…

• Patients having a different type of bariatric surgery including but not limited to duodenal switch, gastric bypass, hand-assisted laparoscopic sleeve gastrectomy
• Sleeve gastrectomy's performed by other surgeons than Dr. Sam Wasser.
• Pregnancy
• Allergic to sugammadex, Zofran or scopolamine
• Chronic Obstructive Pulmonary Disease or Asthma that is uncontrolled
• American Society of Anesthesiologists Score I, IV, V patients

Where it is running

• Virtua Memorial Hospital — Mount Holly, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.